Pesquisas alternativas:
doses devel » dose level (Expandir a Pesquisa), doses derived (Expandir a Pesquisa), doses devoid (Expandir a Pesquisa)
does devel » does level (Expandir a Pesquisa), does deep (Expandir a Pesquisa), does novel (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
drug does » drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa), drug de (Expandir a Pesquisa)
doses devel » dose level (Expandir a Pesquisa), doses derived (Expandir a Pesquisa), doses devoid (Expandir a Pesquisa)
does devel » does level (Expandir a Pesquisa), does deep (Expandir a Pesquisa), does novel (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa), drug disease (Expandir a Pesquisa)
drug does » drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa), drug de (Expandir a Pesquisa)
1
Por Park, Gab-jin, Bae, Soo Hyeon, Park, Wan-Su, Han, Seunghoon, Park, Min-Ho, Shin, Seok-Ho, Shin, Young G, Yim, Dong-Seok
Publicado no Drug Des Devel Ther (2017)
“...PURPOSE: A microdose drug–drug interaction (DDI) study may be a valuable tool for anticipating drug...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“..., this study aimed to evaluate the pharmacokinetic (PK) interactions between these two drugs in healthy males...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Lee, Jieon, Yoon, Seonghae, Shin, Donghoon, Han, HyeKyung, An, Hyungmi, Lee, Jongtae, Lim, Kyoung Soo, Yu, Kyung-Sang, Lee, Howard
Publicado em 2014
“... nomograms may be required in patients with IE, particularly for once-daily dosing. Therapeutic drug...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Guerrero-Orriach, Jose Luis, Escalona Belmonte, Juan Jose, Ramirez Fernandez, Alicia, Ramirez Aliaga, Marta, Rubio Navarro, Manuel, Cruz Mañas, Jose
Publicado no Drug Des Devel Ther (2017)
“... is related to the dose-dependent signal, while the degree of protection is related to the concentration...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Barbarash, Olga, Gruzdeva, Olga, Uchasova, Evgenya, Belik, Ekaterina, Dyleva, Yulia, Karetnikova, Victoria
Publicado no Drug Des Devel Ther (2015)
“..., resulted in a decrease in free fatty acid levels. The positive effect of low-dose atorvastatin (20 mg/day...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Kim, Yo Han, Choi, Hee Youn, Noh, Yook-Hwan, Lee, Shi Hyang, Lim, Hyeong-Seok, Kim, Chin, Bae, Kyun-Seop
Publicado no Drug Des Devel Ther (2015)
“... and high blood pressure. The aim of this study was to investigate the dose proportionality...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Erturk, Ayse, Adnan Akdogan, Remzi, Parlak, Emine, Cure, Erkan, Cumhur Cure, Medine, Ozturk, Cinar
Publicado em 2014
“... transaminase (ALT) normalization at the end of 4 years. CONCLUSION: Increasing ETV dose from 0.5 mg to 1 mg...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Wang, Ying, Sun, Sheng-Gang, Zhu, Sui-Qiang, Liu, Chun-Feng, Liu, Yi-Ming, Di, Qing, Shang, Hui-Fang, Ren, Yan, Xiang, Wei, Chen, Sheng-Di
Publicado no Drug Des Devel Ther (2016)
“... for Parkinson’s disease (PD). A critical dose level above which a better benefit-to-harm ratio exists has not been...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Wu, Jianhui, Zhao, Ming, Wang, Yuji, Wang, Yaonan, Zhu, Haimei, Zhao, Shurui, Gui, Lin, Zhang, Xiaoyi, Peng, Shiqi
Publicado no Drug Des Devel Ther (2017)
“... S180 mice, and has a minimal effective dose of 2 nmol/kg per day. At 200 nmol/kg per day, HMCEF does...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Gahr, Maximilian, Kölle, Markus A, Schönfeldt-Lecuona, Carlos, Lepping, Peter, Freudenmann, Roland W
Publicado em 2011
“... pharmacological profile, including single dosing, predominantly renal excretion, low drug–drug interaction risk...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Min, Jee Sun, Kim, Doyun, Park, Jung Bae, Heo, Hyunjin, Bae, Soo Hyeon, Seo, Jae Hong, Oh, Euichaul, Bae, Soo Kyung
Publicado no Drug Des Devel Ther (2016)
“...BACKGROUND: Evaluating the potential risk of metabolic drug–drug interactions (DDIs) is clinically...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“...Paclitaxel (Taxol), one of the most important anticancer drugs, has been used for therapy...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“... of once-daily dose of tadalafil by the US Food and Drug Administration for the management of ED...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Kim, Yo Han, Choi, Hee Youn, Lim, Hyeong-Seok, Lee, Shi Hyang, Jeon, Hae Sun, Hong, Donghyun, Kim, Seong Su, Choi, Young Kweon, Bae, Kyun-Seop
Publicado no Drug Des Devel Ther (2015)
“.... The aim of this randomized, single-blind, placebo-controlled, single-dose, dose-escalation study...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
16
Por Wu, Guolan, Zheng, Yunliang, Zhou, Huili, Hu, Xingjiang, Liu, Jian, Zhai, You, Zhu, Meixiang, Wu, Lihua, Shentu, Jianzhong
Publicado no Drug Des Devel Ther (2015)
“... oral dose of 0.25–2.0 g dicloxacillin sodium, the maximum plasma drug concentration (C(max...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
“... ejection fraction, giving emphasis to a drug that has a dual-acting inhibition of the neprilysin and renin...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Choi, YoonJung, Han, HyeKyung, Shin, Dongseong, Lim, Kyoung Soo, Yu, Kyung-Sang
Publicado no Drug Des Devel Ther (2015)
“... and esomeprazole after a single oral dose. Both drugs were well-tolerated without any safety issues....”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Tjandrawinata, Raymond R, Setiawati, Effi, Putri, Ratih Sofia Ika, Yunaidi, Danang Agung, Amalia, Fawzia, Susanto, Liana W
Publicado em 2014
“... of the test drug or of the reference drug. Blood samples were drawn immediately before taking the drug...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
“..., given the rising morbidity and mortality due to this disease. The fixed-dose combination of aclidinium...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo